AstraZeneca Aktie
155,00
EUR
+0,55
EUR
+0,36
%
144,58
CHF
-0,75
CHF
-0,51
%
Werbung
AstraZeneca Aktie Analyse
| 02.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.04.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 28.04.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 27.04.23 | AstraZeneca Neutral | UBS AG | |
| 27.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.04.23 | AstraZeneca Overweight | Barclays Capital | |
|
Werbung
|
|||
| 11.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.03.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.03.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 13.03.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.03.23 | AstraZeneca Neutral | UBS AG | |
| 09.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.02.23 | AstraZeneca Neutral | UBS AG | |
| 16.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.02.23 | AstraZeneca Neutral | UBS AG | |
| 10.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.02.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 09.02.23 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.02.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 18.01.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 11.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 15.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.12.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 14.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 11.11.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.11.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.22 | AstraZeneca Neutral | UBS AG | |
| 10.11.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
Werbung
Werbung